{"id":"NCT00127205","sponsor":"SWOG Cancer Research Network","briefTitle":"S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.","officialTitle":"Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-07","primaryCompletion":"2017-12","completion":"2021-03-29","firstPosted":"2005-08-05","resultsPosted":"2019-08-28","lastUpdate":"2021-07-02"},"enrollment":6097,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"clodronate disodium","otherNames":[]},{"type":"DRUG","name":"ibandronate sodium","otherNames":[]},{"type":"DRUG","name":"zoledronic acid","otherNames":[]}],"arms":[{"label":"Arm I","type":"EXPERIMENTAL"},{"label":"Arm II","type":"ACTIVE_COMPARATOR"},{"label":"Arm III","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Zoledronate, clodronate, or ibandronate may delay or prevent bone metastases in patients with nonmetastatic breast cancer. It is not yet known whether zoledronate is more effective than clodronate or ibandronate in treating breast cancer.\n\nPURPOSE: This randomized phase III trial is studying zoledronate to see how well it works compared to clodronate or ibandronate in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.","primaryOutcome":{"measure":"Disease-free Survival","timeFrame":"Disease assessments are completed every 6 months for 5 years then annually for 5 years or until death or recurrence","effectByArm":[{"arm":"Arm I Zoledronate","deltaMin":88,"sd":null},{"arm":"Arm II Clodronate","deltaMin":88,"sd":null},{"arm":"Arm III Ibandronate","deltaMin":87,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.49"},{"comp":"OG000 vs OG001","p":"0.24"},{"comp":"OG000 vs OG002","p":"0.50"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["38979716","32929540"],"seeAlso":["https://nctn-data-archive.nci.nih.gov/"]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":2125},"commonTop":["Pain - Joint","Hot flashes/flushes","Fatigue (asthenia, lethargy, malaise)","Nausea","Pain - Bone"]}}